GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
No information available. |
Summary of Clinical Use ![]() |
DPK-060 (topical formulation) has completed Phase 2 studies to evaluate antimicrobial efficacy in patients with atopic dermatitis (NCT01522391) or with acute external otitis (NCT01447017). |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT01447017 | A Study of DPK-060 to Investigate Clinical Safety and Efficacy in Patients With Acute External Otitis | Phase 2 Interventional | DermaGen AB | ||
NCT01522391 | A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060 | Phase 1/Phase 2 Interventional | DermaGen AB |